UDI in Practice: Implementing Unique Device Identification for Medical Devices
Live online

UDI in Practice: Implementing Unique Device Identification for Medical Devices

From the ANVISA framework (UDI) to international compliance (FDA and EU MDR). A 16-hour live course.

Duration
16 hours
Format
Live online
Certification
HSC Global

About the course

A 16-hour live course on implementing Unique Device Identification (UDI) for medical devices, focusing on the ANVISA framework (RDC 591/2021, RDC 884/2024 and IN 426/2026) with parallels to the FDA (GUDID) and CE Marking / EU MDR (EUDAMED). Classes combine interactive lectures, case studies and practical exercises with an IUDI attribute spreadsheet, an implementation checklist, code reading and an integrated case.

What you will learn

Module 01 / 2 hUDI fundamentals

UDI concept, objectives and benefits; anatomy of the UDI-DI and UDI-PI; data carriers (linear barcode, GS1 DataMatrix, RFID); issuing entities (GS1, HIBCC, ICCBBA); GMDN and EMDN nomenclatures. Practice: reading a real GS1 DataMatrix.

Module 02 / 4 hUDI at ANVISA: framework and database (SIUD)

RDC 591/2021, RDC 884/2024 and IN 426/2026; the SIUD database (registration, mandatory attributes, submission and updating); relationship with registration/notification and labelling; UDI-DI for families, kits, sets and SaMD. Practice: UDI attributes of a Class III product.

Module 03 / 2 hDeadlines, risk classes and responsibilities (ANVISA)

Timeline by risk class (IV, III, II and I); responsibilities of the registration holder, the manufacturer and the importer; early voluntary application and transition; nonconformity and enforcement. Practice: deadlines for a fictitious portfolio.

Module 04 / 3 hPractical implementation and Quality Management

Integrating UDI into the QMS (ISO 13485 / GMP); project workflow: diagnosis, assignment, marking, submission and maintenance; impacts on packaging, labelling, ERP/PLM and change control; common mistakes and audit preparation. Practice: group implementation plan.

Module 05 / 1.5 hUDI at the FDA (United States)

The UDI Rule (21 CFR Part 830) and labelling (21 CFR 801); the GUDID and AccessGUDID databases; differences from the ANVISA model. Practice: guided search in AccessGUDID and comparison with SIUD.

Module 06 / 1.5 hUDI in the European Union (CE Marking / EU MDR)

The UDI system of Regulation (EU) 2017/745: Basic UDI-DI, UDI-DI and UDI-PI; the EUDAMED database and UDI across the device life cycle; particularities of the Basic UDI-DI. Practice: mapping the same product across the three systems.

Module 07 / 1.5 hComparative summary and integrating cases

ANVISA x FDA x EU MDR comparison table; strategy for exporting companies; integrated case study from assignment to submission. Practice: group integrated case.

Module 08 / 0.5 hFinal assessment and close

Final assessment (objective questions + applied case), with a minimum score of 70% for the certificate to be issued; review of questions, individual action plan and delivery of support materials.

Learning objective

Equip participants to explain the concept and structure of UDI (UDI-DI and UDI-PI), interpret and apply the ANVISA framework by risk class, plan and lead UDI/IUDI implementation within the Quality Management System, register and submit data to the ANVISA database (SIUD), and compare the Brazilian model with the FDA (GUDID) and European Union (EUDAMED / EU MDR) systems, supporting export strategies.

Who this course is for

Regulatory Affairs and Quality Assurance (RA/QA) professionals and Brazilian medical device manufacturers. Prerequisite: basic knowledge of medical device regulation (ANVISA registration/notification); familiarity with the QMS (ISO 13485 / GMP) is desirable.